These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23362298)

  • 1. Rapid detection of antibiotic-resistant organism carriage for infection prevention.
    Diekema DJ; Pfaller MA
    Clin Infect Dis; 2013 Jun; 56(11):1614-20. PubMed ID: 23362298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for multidrug-resistant bacteria as a predictive test for subsequent onset of nosocomial infection.
    Galoisy-Guibal L; Soubirou JL; Desjeux G; Dusseau JY; Eve O; Escarment J; Ecochard R
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1233-41. PubMed ID: 17080382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective.
    Backman C; Taylor G; Sales A; Marck PB
    Am J Infect Control; 2011 Jun; 39(5):368-378. PubMed ID: 21429622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations.
    Santos RP; Mayo TW; Siegel JD
    Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative management of multidrug-resistant organisms in health care settings.
    Grota PG
    AORN J; 2007 Sep; 86(3):361-8; quiz 369-72. PubMed ID: 17822641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of the automated risk assessment system for multidrug-resistant organisms (autoRAS-MDRO).
    Hur EY; Jin YJ; Jin TX; Lee SM
    J Hosp Infect; 2018 Feb; 98(2):202-211. PubMed ID: 28807836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance programme for multidrug-resistant bacteria in healthcare-associated infections: an urban perspective in South Brazil.
    Toledo PV; Arend LN; Pilonetto M; Costa Oliveira JC; Luhm KR;
    J Hosp Infect; 2012 Apr; 80(4):351-3. PubMed ID: 22382275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.
    Grgurich PE; Hudcova J; Lei Y; Sarwar A; Craven DE
    Expert Rev Respir Med; 2012 Nov; 6(5):533-55. PubMed ID: 23134248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation precautions for antibiotic-resistant bacteria in healthcare settings.
    Gasink LB; Brennan PJ
    Curr Opin Infect Dis; 2009 Aug; 22(4):339-44. PubMed ID: 19461513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of health care associated infections and bacterial resistance : guidance for good practice].
    Foguena AK; Cometta A; Senn L
    Rev Med Suisse; 2016 Nov; 12(540):2026-2032. PubMed ID: 28696611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic heterogeneity optimizes antimicrobial prescription and enables resistant pathogen control in the intensive care unit.
    Piper GL; Kaplan LJ
    Surg Infect (Larchmt); 2012 Aug; 13(4):194-202. PubMed ID: 22913313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing multidrug-resistant organisms in home care and hospice: surveillance, prevention, and control.
    McGoldrick M; Rhinehart E
    Home Healthc Nurse; 2007 Oct; 25(9):580-6; quiz 587-8. PubMed ID: 18049254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis on the infections change and measures for the multiple drug-resistant bacteria of neurology.
    Zang W
    Pak J Pharm Sci; 2016 May; 29(3 Suppl):1019-22. PubMed ID: 27383494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial resistance of Gram negative bacilli isolated from tertiary-care hospitals in Colombia].
    Briceño DF; Correa A; Valencia C; Torres JA; Pacheco R; Montealegre MC; Ospina D; Villegas MV;
    Biomedica; 2010; 30(3):371-81. PubMed ID: 21713339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial resistance and dissemination of multidrug resistant organisms-A review].
    Wang J; Wang X; Xu H
    Wei Sheng Wu Xue Bao; 2016 Nov; 56(11):1671-9. PubMed ID: 29741829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control.
    Bonten MJ; Austin DJ; Lipsitch M
    Clin Infect Dis; 2001 Nov; 33(10):1739-46. PubMed ID: 11595995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures.
    Mutters NT; Günther F; Frank U; Mischnik A
    J Hosp Infect; 2016 Jun; 93(2):191-6. PubMed ID: 27112045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alliance against MDRO: safeguarding antibiotics].
    Carlet J; Rambaud C; Pulcini C;
    Ann Fr Anesth Reanim; 2012 Sep; 31(9):704-8. PubMed ID: 22925945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.